Arkolith/Insider Trading/OVID/Form 4

Alexander Margaret A.

President and CEO, DirectorOvid Therapeutics Inc. (OVID) · full profile →Form 4 · filed Mar 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$17K
Net Open-Market Flow
-$17K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 23, 2026Sell(S)12K$1.45$17K62K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 26, 2026Grant(A)1.4M—$01.4M

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002036798-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML